Crossmark

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Crossref DOI link: https://doi.org/10.1038/nbt.3471

Published Online: 2016-02-01

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Hao

Song, Chun-Qing

Dorkin, Joseph R

Zhu, Lihua J

Li, Yingxiang http://orcid.org/0000-0003-0835-9280
Wu, Qiongqiong

Park, Angela

Yang, Junghoon

Suresh, Sneha

Bizhanova, Aizhan

Gupta, Ankit

Bolukbasi, Mehmet F

Walsh, Stephen

Bogorad, Roman L

Gao, Guangping

Weng, Zhiping

Dong, Yizhou

Koteliansky, Victor

Wolfe, Scot A

Langer, Robert

Xue, Wen

Anderson, Daniel G
License Information

Text and Data Mining valid from 2016-02-01
More Information

Article History

Received: 18 June 2015

Accepted: 5 January 2016

First Online: 1 February 2016

Competing interests

: D.G.A., H.Y., J.R.K. and W.X. have applied for patents on the subject matter of this paper. D.G.A. is a scientific co-founder of CRISPR Therapeutics.